Atorvaliq + Atorvastatin Interaction
Unknowninteraction on record
Description
• Rifampin: May reduce atorvastatin plasma concentrations. 7.1 Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with ATORVALIQ Atorvastatin is a substrate of CYP3A4 and transporters (e.g., OATP1B1/1B3, P-gp, or BCRP). Atorvastatin plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and transporters.
Source: FDA drug label - atorvaliq